References
1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus From Patients with Pneumonia in China, 2019. N Engl J Med 382:727-733, 2020. doi: 10.1056/NEJMoa2001017.
2. Carod-Artal FJ. Post-COVID-19 Syndrome: Epidemiology, Diagnostic Criteria and Pathogenic Mechanisms Involved. Rev Neurol 72:384-396. English, Spanish, 2021 Jun 1. doi: 10.33588/rn.7211.2021230.
3. Tansey CM, Louie M, Loeb M, et al. One-year Outcomes and Health Care Utilization in Survivors of Severe Acute Respiratory Syndrome. Arch Intern Med 167:1312-1320, 2007. doi: 10.1001/archinte.167.12.1312.
4. Lam MH, Wing YK, Yu MW, et al. Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors: Long-term Follow-up. Arch Intern Med 169:2142-2147, 2009. doi: 10.1001/archinternmed.2009.384.
5. Baraniuk JN, Kern G, Narayan V, Cheema A. Exercise Modifies Glutamate and Other Metabolic Biomarkers in Cerebrospinal Fluid from Gulf War Illness and Myalgic Encephalomyelitis / Chronic Fatigue Syndrome. PLOS ONE 16:e0244116, 2021 Jan 13. doi: 10.1371/journal.pone.0244116.
6. Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Evidence-based Approach to Diagnosis and Management by Clinicians. Rev Environ Health 30:223-249, 2015. doi: 10.1515/reveh-2015-0026.
7. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press, Washington (DC). (US), 2015 Feb 10. doi: 10.17226/19012.
8. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T. Acylcarnitine Deficiency in Chronic Fatigue Syndrome. Clin Infect Dis 18 Suppl 1:S62-S67, 1994 Jan. doi: 10.1093/clinids/18.supplement_1.s62.
9. Ladds E, Rushforth A, Wieringa S, et al. Persistent Symptoms After COVID-19: Qualitative Study of 114 ‘Long COVID’ Patients and Draft Quality Principles for Services. BMC Health Serv Res 20:1144, 2020. doi: 10.1186/s12913-020-06001-y.
10. Amsalem D, Dixon LB, Neria Y. The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health: Current Risks and Recommended Actions. JAMA Psychiatry 78:9-10, 2021. doi: 10.1001/jamapsychiatry.2020.1730.
11. Asprusten TT, Sulheim D, Fagermoen E, Winger A, Skovlund E, Wyller VB. Systemic Exertion Intolerance Disease Diagnostic Criteria Applied on an Adolescent Chronic Fatigue Syndrome Cohort: Evaluation of Subgroup Differences and Prognostic Utility. BMJ Paediatr Open 2:e000233, 2018 Mar 16. doi: 10.1136/bmjpo-2017-000233.
12. White PD, Goldsmith KA, Johnson AL, et al. Comparison of Adaptive Pacing Therapy, Cognitive Behaviour Therapy, Graded Exercise Therapy, and Specialist Medical Care for Chronic Fatigue Syndrome (PACE): A Randomised Trial. Lancet 377:823-836, 2011 Mar 5. doi: 10.1016/S0140-6736(11)60096-2.
13. Miwa S, Takikawa O. [Chronic Fatigue Syndrome and Neurotransmitters]. Nihon Rinsho 65:1005-1010. Japanese, 2007 Jun.
14. Jones MG, Goodwin CS, Amjad S, Chalmers RA. Plasma and Urinary Carnitine and Acylcarnitine in Chronic Fatigue Syndrome. Clin Chim Acta 360:173-177, 2005 Oct. doi: 10.1016/j.cccn.2005.04.029.
15. Reuter SE, Evans AM. Long-chain Acylcarnitine Deficiency in Patients with Chronic Fatigue Syndrome. Potential Involvement of Altered Carnitine Palmitoyltransferase-I Activity. J Intern Med 270:76-84, 2011 Jul. doi: 10.1111/j.1365-2796.2010.02341.x.
16. Kuratsune H, Yamaguti K, Watanabe Y, et al.  Acylcarnitine and Chronic Fatigue Syndrome. in: Carnitine Today. De Simone C, Famularo G Eds. RG Landes Company, Austin, 1997:195-213.
17. Piccoli C, Quarato G, Ripoli M, et al.  HCV Infection Induces Mitochondrial Bioenergetic Unbalance: Causes and Effects. Biochim Biophys Acta 1787:539-546, 2009. doi: 10.1016/j.bbabio.2008.11.008.